Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学TROP2 ADC, Lung Cancer

Andrea Varga

MD, PhD

🏢Gustave Roussy Cancer Campus🌐France

Medical Oncologist and Clinical Researcher

31
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Dr. Andrea Varga is a clinical investigator at Gustave Roussy who has been actively involved in early-phase studies of TROP2-directed ADCs in solid tumors including lung cancer. She participated in TROPION-Lung01 and related datopotamab deruxtecan studies for non-squamous NSCLC. Her research focuses on novel payload delivery and biomarker-driven ADC selection in thoracic and other solid tumors.

Share:

🧪Research Fields 研究领域

TROP2 lung cancer ADC
datopotamab deruxtecan NSCLC
TROPION-Lung01
non-squamous NSCLC ADC
Phase I ADC trials

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Andrea Varga 的研究动态

Follow Andrea Varga's research updates

留下邮箱,当我们发布与 Andrea Varga(Gustave Roussy Cancer Campus)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment